# Junta clínica — PT-pseudo_3f75ae876abe (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_3f75ae876abe",
  "pid": "PT-pseudo_3f75ae876abe",
  "task": 1,
  "psa": 16.8,
  "age": 69,
  "months": 1,
  "pirads": "5",
  "psad": 0.846,
  "psav": 3.33,
  "psap": 11.0,
  "vol": 19.86,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.87284654,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "91 kg",
    "height": "177 cm",
    "bmi": "29.0",
    "bp": "111/83 mmHg",
    "hr": "66 bpm",
    "smoking": "Current smoker (15 pack-yr)",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Jan 2025",
  "enc_ref": "Dr. L. Smits (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit."
    },
    {
      "s": "History",
      "t": "At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket \"None\". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute."
    }
  ],
  "occupation": "retired truck driver",
  "marital": "Married",
  "living": "Lives alone",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Ophthalmology — cataract review",
    "Endocrine — thyroid screening"
  ],
  "alcohol": "6 units / week",
  "exercise": "Limited mobility — chair-based exercises only",
  "ipss": "IPSS score: 16/35 (moderate LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "UMCG (Groningen)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_3f75ae876abe
Task: 1

Encounter: Urology - outpatient on 01 Jan 2025.
Referrer: Dr. L. Smits (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 69-year-old male
  - PSA: 16.8 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.846 ng/mL²
  - PSA velocity: 3.33 ng/mL/yr
  - Prior PSA: 11.0 ng/mL
  - Prostate volume: 19.86 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.87284654 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.

Vitals: weight 91 kg, height 177 cm, BMI 29.0, BP 111/83 mmHg, HR 66 bpm. Smoking: Current smoker (15 pack-yr).

Chief complaint: Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit.

History: At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket "None". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment.

Physical examination: DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute.

Patient info: retired truck driver; Married; Lives alone.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 16/35 (moderate LUTS).

Recent other appointments: Ophthalmology — cataract review; Endocrine — thyroid screening.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.84
  uncertainty  +/- 0.06 epistemic (95% band 0.73-0.95); among patients I cannot tell apart the outcome was 0.63 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 23 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.51: PI-RADS 5, PSA 24.0, PSAD 0.986, age 68, DRE Normal -> BIOPSY (clear). He wrote: "PIRADS 5 needs biopsy"
  2. distance 0.63: PI-RADS 5, PSA 22.0, PSAD 0.696, age 68, DRE Normal -> BIOPSY (clear). He wrote: "Biopsy-naive PIRADS 5 needs biopsy"
  3. distance 0.98: PI-RADS 5, PSA 12.0, PSAD 0.411, age 71, DRE Normal -> BIOPSY (borderline). He wrote: "P5 in 71 years old patient with no major comorbidities"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 23 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines link PI-RADS scores to the indication for biopsy, noting that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy. The guideline also suggests that MRI-directed US-guided prostate biopsy is now the standard of care.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert 1's suggestion of biopsy is not settled by the guideline because the guideline does not provide a definitive threshold for biopsy based solely on PI-RADS 5 in the absence of prior biopsy. Expert-Cohort's criterion, which matches the reading urologist in 24 of 24 cases, is not settled because the guideline does not mandate a specific action for a PI-RADS 5 lesion in this exact scenario without further context.

WHAT WE STILL NEED
The panel already contains the following known facts:
*   PI-RADS score: 5, which is $\ge 3$, which triggers the consideration for biopsy according to the guideline.
*   Prior biopsy status: None, which is a factor noted in the guideline regarding biopsy-naïve patients.
*   PSA density: 0.846 ng/mL², which is significantly above the threshold of $0.20 \text{ ng/mL/cc}$ mentioned in the guideline for omitting biopsy when MRI is negative and clinical suspicion is low.
*   The guideline requires establishing whether the clinical suspicion of PCa is high enough to warrant the biopsy, as the guideline suggests considering targeted biopsy with perilesional sampling when MRI is positive (PI-RADS $\ge 4$).
*   The specific details of the mpMRI prose and the PSA trajectory are needed to determine if the clinical suspicion meets the threshold for biopsy as per the guideline.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case strongly suggests biopsy based on the expert consensus, but we must establish the specific details from the MRI report and PSA trend to confirm the clinical suspicion level required by the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What does the mpMRI prose state regarding the lesion size, zone, and extraprostatic extension?
  psa_trend (get_psa_trend) -> What does the serial PSA trend show?
  previous_notes (get_previous_notes) -> What does the previous notes state regarding the prior biopsy status, number of biopsy sessions, and planned treatment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What does the radiology_report state regarding the lesion size, zone, and extraprostatic extension?
  Q2. What does the psa_trend show regarding the serial PSA values?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate Multiparametric MRI
Facility: UMCG Groningen
Date: 28 December 2024
Clinical indication: Evaluation of rising PSA (16.8 ng/mL) and moderate lower urinary tract symptoms.
FINDINGS:
Prostate volume: 19.86 mL.
T2-weighted sequences highlight a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm. Marginal capsular bulging is present without frank extraprostatic extension.
Diffusion-weighted imaging exhibits marked signal restriction alongside correspondingly low ADC values. Dynamic contrast-enhanced sequences demonstrate early, focal enhancement localized to the lesion.
Seminal vesicles maintain normal size and signal characteristics. No suspicious lymphadenopathy or osseous abnormalities are detected.
IMPRESSION:
PI-RADS 5 lesion in the right anterior mid-gland.
Prostate volume 19.86 mL.
PSAD 0.846 ng/mL/mL.
csPCa predicted probability 0.87284654.
What does the mpMRI prose state regarding the lesion size, zone, and extraprostatic extension? The lesion is a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm, with marginal capsular bulging but no frank extraprostatic extension.

psa_trend
{"date": "Nov 2022", "val": 2.8}
{"date": "Jul 2023", "val": 5.1}
{"date": "Apr 2024", "val": 9.2}
{"date": "Jan 2025", "val": 16.8}
What does the serial PSA trend show regarding the serial PSA values? The serial PSA trend shows values of 2.8 ng/mL in Nov 2022, 5.1 ng/mL in Jul 2023, 9.2 ng/mL in Apr 2024, and 16.8 ng/mL in Jan 2025.

previous_notes
{"date": "11 Jul 2023", "author": "Dr. L. Smits (GP)", "text": "Prostate-specific antigen concentrations rose from 7.4 ng/mL during November 2022 to 10.0 ng/mL on recent assessment. Digital rectal examination remained unremarkable. Lower urinary tract symptoms are moderate, absent any hematuria or unexplained weight loss."}
{"date": "12 Jan 2023", "author": "Dr. L. Smits (GP)", "text": "An initial prostate-specific antigen reading of 7.4 ng/mL was recorded in November 2022. Sustained elevation above laboratory reference limits was confirmed during a January 2023 follow-up. He is a retired truck driver experiencing moderate lower urinary tract symptoms without acute urinary retention."}
What does the previous notes state regarding the prior biopsy status, number of biopsy sessions, and planned treatment? Prior biopsy status: "None". Number of biopsy sessions: "None". Planned treatment: "None recorded".

WHAT I DID NOT OPEN
family-history anamnesis, because the clinical decision hinges on the imaging and PSA trajectory, which have been retrieved.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS 5 lesion in the right anterior mid-gland.
PSA velocity of 3.33 ng/mL/yr.
Prior biopsy status is "None".

Findings that argue AGAINST sampling this patient now:
nothing

WHERE THIS LEANS
The findings strongly point towards a biopsy due to the PI-RADS 5 score and the lack of prior biopsy, which aligns with the expert consensus and the EAU guideline's consideration for high clinical suspicion.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 16.80 ng/mL over 4 points spanning 26 months; velocity +6.39 ng/mL per year; doubling time about 10 months.
PROJECTION at 6 months: 31.1 ng/mL, conformal 95% band 8.9-108.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.84
  uncertainty  +/- 0.05 epistemic (95% band 0.74-0.93), of which 0.00 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.84  ('firm' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.84  ('firm' tier, fusion_nolab)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

Confidence the trace model expects here: clear. Weights it expects: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened by the registrar—the radiology report, PSA trend, and previous notes—directly address the moderator's questions.

ALIGNMENT WITH THE PANEL
The retrieved evidence strongly aligns with the PANEL-PROTOCOL's answer of BIOPSY, as the PI-RADS 5 score was retrieved, which fired the cohort criterion.

THE OPEN QUESTIONS, ONE BY ONE
Q1. The radiology report states the lesion is a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm, with marginal capsular bulging but no frank extraprostatic extension.
Q2. The PSA trend shows values of 2.8 ng/mL in Nov 2022, 5.1 ng/mL in Jul 2023, 9.2 ng/mL in Apr 2024, and 16.8 ng/mL in Jan 2025.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS 5 score is the most decisive variable as it directly triggered the cohort criterion, which the panel protocol confirms. The lack of prior biopsy is also a significant factor noted by the trace model.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the retrieved data, particularly the PI-RADS 5 finding and the lack of prior biopsy, strongly supports the panel's decision.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the PI-RADS 5 finding directly triggered the cohort criterion, which is supported by the lack of prior biopsy. This decision is further reinforced by the rising PSA trajectory, showing a velocity of 3.33 ng/mL/yr, and the absence of prior pathology. The evidence converged on a biopsy due to the high-risk imaging finding and the biopsy-naïve status.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes
